NASDAQ · Healthcare · Medical - Diagnostics & Research
Burning Rock Biotech Limited
BNR
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. CEO Yusheng Han · Market cap $17.8M.
$16.76
-0.07 · -0.42%
52w hi $41.7252w lo $2.26
Off 52w high 50.4%
59
ROUTINE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 31 | Yusheng Han | Buy | 314,870 | $17.36 | +$5.47M | 59 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay